1 Min Read
June 5 (Reuters) - Becton Dickinson And Co
* BD receives FDA 510(K) clearance for molecular test for harmful intestinal bacteria causing infectious diarrhea Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.